Cargando…

Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma

Primary central nervous system lymphoma (PCNSL) carries a dismal prognosis in elderly patients above 70 years of age with a median overall survival of 6 months. Novel therapeutic agents are urgently needed to improve survival outcomes in this age group. We describe the clinical presentation, diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuhlman, Justin J, Alhaj Moustafa, Muhamad, Jiang, Liuyan, Wang, Jing, Gupta, Vivek, Tun, Han W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015786/ https://www.ncbi.nlm.nih.gov/pubmed/35444484 http://dx.doi.org/10.2147/BLCTT.S360442

Ejemplares similares

Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy
por: Wang, Jing, et al.
Publicado: (2022)

Primary Cauda Equina Lymphoma Treated with CNS-Centric Approach: A Case Report and Literature Review
por: Kuhlman, Justin J, et al.
Publicado: (2021)

Primary HHV-8 (-) Effusion-Based Non-Germinal Center B Cell Diffuse Large B Cell Lymphoma Successfully Treated with Standard Anthracycline-Based Chemoimmunotherapy
por: Kuhlman, Justin, et al.
Publicado: (2021)

Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes
por: Kimbrough, ErinMarie O, et al.
Publicado: (2022)

Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis
por: Kuhlman, Justin J., et al.
Publicado: (2021)

(90)Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases
por: Wang, Jing, et al.
Publicado: (2023)

Macrophage Activation Led Acute Heart Failure Managed Successfully with Immunosuppression
por: Seegobin, Karan, et al.
Publicado: (2021)

BRAF p.V600E associated poly-neoplastic syndrome
por: Alhaj Moustafa, Muhamad, et al.
Publicado: (2021)

Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma
por: Davis, Jordan, et al.
Publicado: (2023)

Ibrutinib in primary central nervous system diffuse large B-cell lymphoma
por: T Low, Justin, et al.
Publicado: (2020)

Successful Non-Transplant Treatment of Double Hit Richter Transformation with Long-Term Remission
por: Seegobin, Karan, et al.
Publicado: (2021)

Systemic ALK‐positive anaplastic large cell lymphoma with bilateral optic neurolymphomatosis resulting in permanent blindness
por: Seegobin, Karan, et al.
Publicado: (2020)

Advances in the treatment of newly diagnosed primary central nervous system lymphomas
por: Qian, Liren, et al.
Publicado: (2017)

Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective
por: Thomas, Alice, et al.
Publicado: (2023)

Cerebellar primary central nervous system lymphoma: Case series report
por: He, Minglian, et al.
Publicado: (2022)

Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review
por: Nepal, Gaurav, et al.
Publicado: (2022)

Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003–2018)
por: Seegobin, Karan, et al.
Publicado: (2022)

T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Presenting as a Primary Central Nervous System Lymphoma
por: Advani, Pooja, et al.
Publicado: (2015)

Central Nervous System Lymphoma: The Great Mimicker—A Single-Institution Retrospective Study
por: Bazer, Danielle A., et al.
Publicado: (2023)

Multiply Relapsed Secondary CNS Non-Germinal Center Diffuse Large B-Cell Lymphoma Successfully Treated with CNS-Centric Therapy
por: Fournier, Lyndsey L, et al.
Publicado: (2023)

Hypercalcemia, Renal Failure, and Skull Lytic Lesions: Follicular Lymphoma Masquerading as Multiple Myeloma
por: Alhaj Moustafa, Muhamad, et al.
Publicado: (2013)

Clinical outcomes of newly diagnosed primary CNS lymphoma treated with ibrutinib‐based combination therapy: A real‐world experience of off‐label ibrutinib use
por: Chen, Feili, et al.
Publicado: (2020)

Follicular lymphoma associated paraneoplastic myositis
por: Melody, Megan, et al.
Publicado: (2020)

ML-08 Safety and efficacy of consolidation cytarabine for newly-diagnosed primary central nervous system lymphoma
por: Sasaki, Nobuyoshi, et al.
Publicado: (2020)

Primary diffuse large B‐cell lymphoma presenting as acute appendicitis: A report of 2 cases and a literature review
por: Fernandez Turizo, Maria Jose, et al.
Publicado: (2020)

Ibrutinib Treatment of Mantle Cell Lymphoma Relapsing at Central Nervous System: A Case Report and Literature Review
por: Mannina, Donato, et al.
Publicado: (2017)

Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A PRISMA-Compliant Single-Arm Meta-Analysis
por: Lv, Liwei, et al.
Publicado: (2021)

Orelabrutinib versus ibrutinib for patients with refractory/relapsed primary central nervous system lymphoma: An efficacy and safety analysis
por: Qiao, Lijiao, et al.
Publicado: (2023)

Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
por: Yuan, Xianggui, et al.
Publicado: (2022)

Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

An experience with ibrutinib monotherapy for Richter’s syndrome isolated in the central nervous system
por: Nato, Yuma, et al.
Publicado: (2022)

Ibrutinib Treatment through Nasogastric Tube in a Comatose Patient with Central Nervous System Localization of Mantle Cell Lymphoma
por: Alsuliman, Tamim, et al.
Publicado: (2018)

Distal chromosome 1q aberrations and initial response to ibrutinib in central nervous system relapsed mantle cell lymphoma
por: Hansen, Marcus Høy, et al.
Publicado: (2021)

The Efficacy and Safety of Cytarabine on Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Zheng, Xiaohong, et al.
Publicado: (2020)

ML-16 First clinical experience of administration of Tirabrutinib for the patients with newly diagnosed primary central nervous system lymphoma
por: Onodera, Sho, et al.
Publicado: (2021)

Successful treatment of IgG4‐related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
por: Seegobin, Karan, et al.
Publicado: (2021)

Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy
por: Abston, Eric, et al.
Publicado: (2020)

Clinical Characteristics and Treatment of Listeria monocytogenes Infections in the Central Nervous System
por: Xu, Xiaojiao, et al.
Publicado: (2023)

P1127: FINAL ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI-CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL
por: Verner, Emma, et al.
Publicado: (2023)

Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib
por: Christoforidou, Anna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9e56bones3mctgaukr2j3ilhc2